![]() |
產地 | 進口、國產 |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS11658 |
應用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 |
CAS編號 | |
抗體名 | Anti-TDRD9/HIG1 |
克隆性 | |
靶點 | 詳見說明書 |
適應物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human TDRD9/HIG1 |
全、新、優(yōu)、品、好四大特點:
缺氧誘導蛋白HIG1抗體規(guī)格 全:公司提供上萬種產品,涵蓋了生物試劑,elisa試劑盒,標準品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產品在我司都能找到。
新:產品更新速度較快,基本上每周都有新產品出現。
優(yōu):產品質量好,投訴比較少。
好:我公司具有優(yōu)質的技術團隊,產品一旦售出,實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。
缺氧誘導蛋白HIG1抗體規(guī)格 英文名稱 Anti-TDRD9/HIG1
中文名稱 缺氧誘導蛋白HIG1抗體規(guī)格
別 名 C14orf75; chromosome 14 open reading frame 75; HIG 1; Hypoxia inducible HIG 1; MGC135025; Putative ATP dependent RNA helicase TDRD9; Putative ATP-dependent RNA helicase TDRD9; TDRD 9; Tdrd9; TDRD9_HUMAN ; Tudor domain containing 9; Tudor domain containing protein 9; Tudor domain-containing protein 9.
產品屬性:
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Dog, Cow, Horse
產品類型 一抗
研究領域 細胞生物 表觀遺傳學
蛋白分子量 predicted molecular weight: 155kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TDRD9/HIG1
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
缺氧誘導蛋白HIG1抗體規(guī)格 產品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
(石蠟切片需做抗原修復)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 Probable ATP-binding RNA helicase which plays a central role during spermatogenesis by repressing transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Its association with PIWIL4 and the piP-bodies suggests a participation in the secondary piRNAs metabolic process.
Function : Probable ATP-binding RNA helicase which plays a central role during spermatogenesis by repressing transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Its association with PIWIL4 and the piP-bodies suggests a participation in the secondary piRNAs metabolic process
Subunit : Interacts with piRNA-associated proteins PIWIL1 and PIWIL4
Subcellular Location : Cytoplasm. Nucleus. Component of the nuage, also named P granule, a germ-cell-specific organelle required to repress transposon during meiosis. Specifically localizes to piP-bodies, a subset of the nuage which contains secondary piRNAs. PIWIL2 is required for its localization to piP-bodies.
Similarity : Belongs to the DEAD box helicase family. DEAH subfamily.
Contains 1 helicase ATP-binding domain.
Contains 1 helicase C-terminal domain.
Contains 1 Tudor domain.
實驗流程:
正在熱銷的相關產品:
Anti-TSH/FITC 熒光素標記促甲狀腺素抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Tranthyretin 甲狀腺素運載蛋白(抗原)Multi-class antibodies規(guī)格: 0.5mg
包含氧化還原酶的WW域抗體 Anti-WWOX 0.1ml
STARD5 英文名稱: 促黃體激素誘導蛋白5抗體 0.2ml
EphB6 英文名稱: 酪酸蛋白激酶受體B6抗體 0.1ml
Rhesus antibody Rh phospho-IKK beta(Ser476) 磷酸化KB抑制蛋白激酶β抗體 規(guī)格 0.1ml
Tranthyretin 甲狀腺素運載蛋白(抗原)Multi-class antibodies規(guī)格: 0.5mg
Anti-RIP2/FITC 熒光素標記受體結合絲氨酸蘇氨酸激酶2抗體IgGMulti-class antibodies規(guī)格: 0.2ml
5-LOX (5-lipoxygenase) 5-脂氧合酶抗原Multi-class antibodies規(guī)格: 0.5mg
氫通道蛋白抗體 Anti-NHE1 0.2ml
STEAP1 英文名稱: 跨膜上皮1抗原抗體 0
ZN521 英文名稱: 鋅指蛋白521抗體 0.1ml
Rhesus antibody Rh Phospho-p70 S6 Kinase Beta (Thr228) 磷酸化核糖體S6蛋白激酶β2抗體 規(guī)格 0.1ml
5-LOX (5-lipoxygenase) 5-脂氧合酶抗原Multi-class antibodies規(guī)格: 0.5mg
ALP-B(Mouse Bone-specific Alkphase B) ELISA Kit 小鼠骨特異性堿性磷酸酶BMulti-class antibodies規(guī)格: 48T
Anti-CD55/DAF/FITC 熒光素標記衰變加速因子CD55抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh DQX1 DQX1蛋白抗體 規(guī)格 0.2ml
TOXO IgM 弓形蟲抗體 IgM(捕獲法二步法)
ASK1 英文名稱: 細胞凋亡信號調節(jié)激酶1抗體 0.1ml
ApoB 英文名稱: 載脂蛋白B抗體 0.1ml
Anti-CD55/DAF/FITC 熒光素標記衰變加速因子CD55抗體IgGMulti-class antibodies規(guī)格: 0.2ml
人鼻病毒(RhV)ELISA試劑盒 96T/48T 試劑盒 組裝/原裝
兔子壞死因子α(TNF-α)免疫試劑盒 Rabbit Tumor necrosis factor α,TNFα ELISA Kit
絲酸/蘇酸蛋白激酶B-raf(BRAF)ELISA試劑盒 ,英文名: BRAF ELISA Kit
Peanagglinin,PNAELISA試劑盒花生凝集素(PNA)ELISA試劑盒規(guī)格:96T/48T
guineapigIerferonγ,IFN-γELISA試劑盒豚鼠γ干擾素(IFN-γ)ELISA試劑盒規(guī)格:96T/48T
Humanai-deoxyribonucleaseB,ai-DNaseBELISAKit人抗DNA酶B抗體(ai-DNaseB)ELISA試劑盒規(guī)格:96T/48T
大鼠糖原磷酸化酶(GP)ELISA試劑盒 ,英文名: GP ELISA Kit
人熱休克蛋白40(HSP-40)ELISA檢測試劑盒HumanHeatShockProtein40,HSP-40ELISAKit 96T/48T
駱駝谷胱甘肽過氧化物酶(GSH-PX)免疫試劑盒 Camel Glathione Peroxidase,GSH-PX ELISA kit
CLIAKitforPSA(Mouseprostatespecificaigen)ELISAKit小鼠特異性抗原規(guī)格:48T/96T
石蠟切片組織ANDROGEECEPTOR蛋白表達熒光顯微鏡檢測試劑盒10/20次
ELISAKitHDL人規(guī)格:48T/96T
缺氧誘導蛋白HIG1抗體規(guī)格 大鼠細胞周期素D2(Cyclin-D2)ELISA試劑盒 ,英文名: Cyclin-D2 ELISA Kit
人庚型肝炎病毒IgG(HGV-IgG)ELISA檢測試劑盒HumanHepatitisGvirusIgG,HGV-IgGELISAKit 96T/48T
大鼠Ⅲ型前膠原氨基端肽(PⅢ)免疫試劑盒 Rat procollagen Ⅲ N-terminal peptide,PⅢ ELISA Kit
CLIAKitforSA(HumanSialicacid)ELISAKit人唾液酸規(guī)格:48T/96T
石蠟切片結締組織(CONNECTIVETISSUE)摩羅利(mallory)染色試劑盒50次
ELISAKitFⅫa人活化凝血因子Ⅻ規(guī)格:48T/96T
技術外包服務:
★缺氧誘導蛋白HIG1抗體規(guī)格 分子生物學:質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學:基因合成、引物合成、基因測序、載體構建等
★蛋白工程:原核、哺乳動物蛋白表達系統等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程:細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。